Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sherif R. Zaki is active.

Publication


Featured researches published by Sherif R. Zaki.


The Lancet | 1999

Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia

Kaw Bing Chua; Khean Jin Goh; Kum Thong Wong; Adeeba Kamarulzaman; Patrick Seow Koon Tan; Thomas G. Ksiazek; Sherif R. Zaki; George Paul; Sai Kit Lam; Chong Tin Tan

BACKGROUND Between February and April, 1999, an outbreak of viral encephalitis occurred among pig-farmers in Malaysia. We report findings for the first three patients who died. METHODS Samples of tissue were taken at necropsy. Blood and cerebrospinal-fluid (CSF) samples taken before death were cultured for viruses, and tested for antibodies to viruses. FINDINGS The three pig-farmers presented with fever, headache, and altered level of consciousness. Myoclonus was present in two patients. There were signs of brainstem dysfunction with hypertension and tachycardia. Rapid deterioration led to irreversible hypotension and death. A virus causing syncytial formation of vero cells was cultured from the CSF of two patients after 5 days; the virus stained positively with antibodies against Hendra virus by indirect immunofluorescence. IgM capture ELISA showed that all three patients had IgM antibodies in CSF against Hendra viral antigens. Necropsy showed widespread microinfarction in the central nervous system and other organs resulting from vasculitis-induced thrombosis. There was no clinical evidence of pulmonary involvement. Inclusion bodies likely to be of viral origin were noted in neurons near vasculitic blood vessels. INTERPRETATION The causative agent was a previously undescribed paramyxovirus related to the Hendra virus. Close contact with infected pigs may be the source of the viral transmission. Clinically and epidemiologically the infection is distinct from infection by the Hendra virus. We propose that this Hendra-like virus was the cause of the outbreak of encephalitis in Malaysia.


The New England Journal of Medicine | 1994

Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized Disease

Jeffrey S. Duchin; Frederick Koster; Clarence J. Peters; Gary Simpson; Bruce Tempest; Sherif R. Zaki; Thomas G. Ksiazek; Pierre E. Rollin; Stuart T. Nichol; Edith Umland; Ronald L. Moolenaar; Susan E. Reef; Kurt B. Nolte; Margaret M. Gallaher; Jay C. Butler; Robert F. Breiman

Background In May 1993 an outbreak of severe respiratory illness occurred in the southwestern United States. A previously unknown hantavirus was identified as the cause. In Asia hantaviruses are associated with hemorrhagic fever and renal disease. They have not been known as a cause of human disease in North America. Methods We analyzed clinical, laboratory, and autopsy data on the first 17 persons with confirmed infection from this newly recognized strain of hantavirus. Results The mean age of the patients was 32.2 years (range, 13 to 64); 61 percent were women, 72 percent were Native American, 22 percent white, and 6 percent Hispanic. The most common prodromal symptoms were fever and myalgia (100 percent), cough or dyspnea (76 percent), gastrointestinal symptoms (76 percent), and headache (71 percent). The most common physical findings were tachypnea (100 percent), tachycardia (94 percent), and hypotension (50 percent). The laboratory findings included leukocytosis (median peak cell count, 26,000 per cu...


Emerging Infectious Diseases | 2002

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Daniel B. Jernigan; Pratima L. Raghunathan; Beth P. Bell; Ross J. Brechner; Eddy A. Bresnitz; Jay C. Butler; Marty Cetron; Mitch Cohen; Timothy J. Doyle; Marc Fischer; Carolyn M. Greene; Kevin S. Griffith; Jeannette Guarner; James L. Hadler; James A. Hayslett; Richard F. Meyer; Lyle R. Petersen; Michael R. Phillips; Robert W. Pinner; Tanja Popovic; Conrad P. Quinn; Jennita Reefhuis; Dori B. Reissman; Nancy E. Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L. Swerdlow; Fred C. Tenover; Marc S. Traeger

In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.


Journal of Virology | 2005

Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals

Taronna R. Maines; Xui Hua Lu; Steven M. Erb; Lindsay Edwards; Jeannette Guarner; Patricia W. Greer; Doan C. Nguyen; Kristy J. Szretter; Li-Mei Chen; Pranee Thawatsupha; Malinee Chittaganpitch; Sunthareeya Waicharoen; Diep T. Nguyen; Tung Nguyen; Hanh Nguyen; Jae-Hong Kim; Long T. Hoang; Chun Kang; Lien S. Phuong; Wilina Lim; Sherif R. Zaki; Ruben O. Donis; Nancy J. Cox; Jacqueline M. Katz; Terrence M. Tumpey

ABSTRACT The spread of highly pathogenic avian influenza H5N1 viruses across Asia in 2003 and 2004 devastated domestic poultry populations and resulted in the largest and most lethal H5N1 virus outbreak in humans to date. To better understand the potential of H5N1 viruses isolated during this epizootic event to cause disease in mammals, we used the mouse and ferret models to evaluate the relative virulence of selected 2003 and 2004 H5N1 viruses representing multiple genetic and geographical groups and compared them to earlier H5N1 strains isolated from humans. Four of five human isolates tested were highly lethal for both mice and ferrets and exhibited a substantially greater level of virulence in ferrets than other H5N1 viruses isolated from humans since 1997. One human isolate and all four avian isolates tested were found to be of low virulence in either animal. The highly virulent viruses replicated to high titers in the mouse and ferret respiratory tracts and spread to multiple organs, including the brain. Rapid disease progression and high lethality rates in ferrets distinguished the highly virulent 2004 H5N1 viruses from the 1997 H5N1 viruses. A pair of viruses isolated from the same patient differed by eight amino acids, including a Lys/Glu disparity at 627 of PB2, previously identified as an H5N1 virulence factor in mice. The virus possessing Glu at 627 of PB2 exhibited only a modest decrease in virulence in mice and was highly virulent in ferrets, indicating that for this virus pair, the K627E PB2 difference did not have a prevailing effect on virulence in mice or ferrets. Our results demonstrate the general equivalence of mouse and ferret models for assessment of the virulence of 2003 and 2004 H5N1 viruses. However, the apparent enhancement of virulence of these viruses in humans in 2004 was better reflected in the ferret.


Clinical Infectious Diseases | 2000

Deaths of Children during an Outbreak of Hand, Foot, and Mouth Disease in Sarawak, Malaysia: Clinical and Pathological Characteristics of the Disease

L. G. Chan; Umesh D. Parashar; M. S. Lye; F. Ong; Sherif R. Zaki; James Alexander; K. K. Ho; Linda L. Han; Mark A. Pallansch; Abu Bakar Suleiman; M. Jegathesan; Larry J. Anderson

From April through June 1997, 29 previously healthy children aged <6 years (median, 1.5 years) in Sarawak, Malaysia, died of rapidly progressive cardiorespiratory failure during an outbreak of hand, foot, and mouth disease caused primarily by enterovirus 71 (EV71). The case children were hospitalized after a short illness (median duration, 2 days) that usually included fever (in 100% of case children), oral ulcers (66%), and extremity rashes (62%). The illness rapidly progressed to include seizures (28%), flaccid limb weakness (17%), or cardiopulmonary symptoms (of 24 children, 17 had chest radiographs showing pulmonary edema, and 24 had echocardiograms showing left ventricular dysfunction), resulting in cardiopulmonary arrest soon after hospitalization (median time, 9 h). Cardiac tissue from 10 patients showed normal myocardium, but central nervous system tissue from 5 patients showed inflammatory changes. Brain-stem specimens from 2 patients were available, and both specimens showed extensive neuronal degeneration, inflammation, and necrosis, suggesting that a central nervous system infection was responsible for the disease, with the cardiopulmonary dysfunction being neurogenic in origin. EV71 and possibly an adenovirus, other enteroviruses, or unknown cofactors are likely responsible for this rapidly fatal disease.


The Journal of Infectious Diseases | 1999

The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995

Ali S. Khan; F. Kweteminga Tshioko; David L. Heymann; Bernard Le Guenno; Pierre Nabeth; Barbara Kerstiëns; Yon Fleerackers; Peter H. Kilmarx; Guénaël Rodier; Okumi Nkuku; Pierre E. Rollin; Anthony Sanchez; Sherif R. Zaki; Robert Swanepoel; Oyewale Tomori; Stuart T. Nichol; C. J. Peters; Jean-Jacques Muyembe-Tamfum; Thomas G. Ksiazek

In May 1995, an international team characterized and contained an outbreak of Ebola hemorrhagic fever (EHF) in Kikwit, Democratic Republic of the Congo. Active surveillance was instituted using several methods, including house-to-house search, review of hospital and dispensary logs, interview of health care personnel, retrospective contact tracing, and direct follow-up of suspect cases. In the field, a clinical case was defined as fever and hemorrhagic signs, fever plus contact with a case-patient, or fever plus at least 3 of 10 symptoms. A total of 315 cases of EHF, with an 81% case fatality, were identified, excluding 10 clinical cases with negative laboratory results. The earliest documented case-patient had onset on 6 January, and the last case-patient died on 16 July. Eighty cases (25%) occurred among health care workers. Two individuals may have been the source of infection for >50 cases. The outbreak was terminated by the initiation of barrier-nursing techniques, health education efforts, and rapid identification of cases.


Clinical Infectious Diseases | 2004

Rickettsia parkeri: A Newly Recognized Cause of Spotted Fever Rickettsiosis in the United States

Christopher D. Paddock; John W. Sumner; James A. Comer; Sherif R. Zaki; Cynthia S. Goldsmith; Jerome Goddard; Susan L. F. McLellan; Cynthia L. Tamminga; Christopher A. Ohl

Ticks, including many that bite humans, are hosts to several obligate intracellular bacteria in the spotted fever group (SFG) of the genus Rickettsia. Only Rickettsia rickettsii, the agent of Rocky Mountain spotted fever, has been definitively associated with disease in humans in the United States. Herein we describe disease in a human caused by Rickettsia parkeri, an SFG rickettsia first identified >60 years ago in Gulf Coast ticks (Amblyomma maculatum) collected from the southern United States. Confirmation of the infection was accomplished using serological testing, immunohistochemical staining, cell culture isolation, and molecular methods. Application of specific laboratory assays to clinical specimens obtained from patients with febrile, eschar-associated illnesses following a tick bite may identify additional cases of R. parkeri rickettsiosis and possibly other novel SFG rickettsioses in the United States.


PLOS Pathogens | 2009

Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats

Jonathan S. Towner; Brian R. Amman; Tara K. Sealy; Serena A. Carroll; James A. Comer; Alan Kemp; Robert Swanepoel; Christopher D. Paddock; Stephen Balinandi; Marina L. Khristova; Pierre Formenty; César G. Albariño; David Miller; Zachary Reed; John Kayiwa; James N. Mills; Deborah Cannon; Patricia W. Greer; Emmanuel Byaruhanga; Eileen C. Farnon; Patrick Atimnedi; Samuel Okware; Edward Katongole-Mbidde; Robert Downing; Jordan W. Tappero; Sherif R. Zaki; Thomas G. Ksiazek; Stuart T. Nichol; Pierre E. Rollin

In July and September 2007, miners working in Kitaka Cave, Uganda, were diagnosed with Marburg hemorrhagic fever. The likely source of infection in the cave was Egyptian fruit bats (Rousettus aegyptiacus) based on detection of Marburg virus RNA in 31/611 (5.1%) bats, virus-specific antibody in bat sera, and isolation of genetically diverse virus from bat tissues. The virus isolates were collected nine months apart, demonstrating long-term virus circulation. The bat colony was estimated to be over 100,000 animals using mark and re-capture methods, predicting the presence of over 5,000 virus-infected bats. The genetically diverse virus genome sequences from bats and miners closely matched. These data indicate common Egyptian fruit bats can represent a major natural reservoir and source of Marburg virus with potential for spillover into humans.


Emerging Infectious Diseases | 2005

Virology, Pathology, and Clinical Manifestations of West Nile Virus Disease

Edward B. Hayes; James J. Sejvar; Sherif R. Zaki; Robert S. Lanciotti; Amy V. Bode; Grant L. Campbell

Virologic characteristics of WNV likely interact with host factors in the pathogenesis of fever, meningitis, encephalitis, and flaccid paralysis.


Journal of Virology | 2007

Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice

Kristy J. Szretter; Shivaprakash Gangappa; Xuihua Lu; Chalanda Smith; Wun-Ju Shieh; Sherif R. Zaki; Suryaprakash Sambhara; Terrence M. Tumpey; Jacqueline M. Katz

ABSTRACT Highly pathogenic avian H5N1 influenza viruses are now widespread in poultry in Asia and have recently spread to some African and European countries. Interspecies transmission of these viruses to humans poses a major threat to public health. To better understand the basis of pathogenesis of H5N1 viruses, we have investigated the role of proinflammatory cytokines in transgenic mice deficient in interleukin-6 (IL-6), macrophage inflammatory protein 1 alpha (MIP-1α), IL-1 receptor (IL-1R), or tumor necrosis factor receptor 1 (TNFR1) by the use of two avian influenza A viruses isolated from humans, A/Hong Kong/483/97 (HK/483) and A/Hong Kong/486/97 (HK/486), which exhibit high and low lethality in mice, respectively. The course of disease and the extent of virus replication and spread in IL-6- and MIP-1α-deficient mice were not different from those observed in wild-type mice during acute infection with 1,000 50% mouse infective doses of either H5N1 virus. However, with HK/486 virus, IL-1R-deficient mice exhibited heightened morbidity and mortality due to infection, whereas no such differences were observed with the more virulent HK/483 virus. Furthermore, TNFR1-deficient mice exhibited significantly reduced morbidity following challenge with either H5N1 virus but no difference in viral replication and spread or ultimate disease outcome compared with wild-type mice. These results suggest that TNF-α may contribute to morbidity during H5N1 influenza virus infection, while IL-1 may be important for effective virus clearance in nonlethal H5N1 disease.

Collaboration


Dive into the Sherif R. Zaki's collaboration.

Top Co-Authors

Avatar

Wun-Ju Shieh

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Christopher D. Paddock

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Pierre E. Rollin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cynthia S. Goldsmith

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Thomas G. Ksiazek

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Stuart T. Nichol

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Julu Bhatnagar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Patricia W. Greer

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Dianna M. Blau

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge